CY1104990T1 - Δομες και μεθοδοι για χορηγηση κανναβης σε ασθενεις - Google Patents

Δομες και μεθοδοι για χορηγηση κανναβης σε ασθενεις

Info

Publication number
CY1104990T1
CY1104990T1 CY20061100291T CY061100291T CY1104990T1 CY 1104990 T1 CY1104990 T1 CY 1104990T1 CY 20061100291 T CY20061100291 T CY 20061100291T CY 061100291 T CY061100291 T CY 061100291T CY 1104990 T1 CY1104990 T1 CY 1104990T1
Authority
CY
Cyprus
Prior art keywords
cannabis
cavity
chemical
support layer
skin
Prior art date
Application number
CY20061100291T
Other languages
English (en)
Inventor
Lawrence Lea Brooke
Cal Cedric Herrmann
Su Il Yum
Original Assignee
Patchtek Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Patchtek Inc. filed Critical Patchtek Inc.
Publication of CY1104990T1 publication Critical patent/CY1104990T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Μία διαδερμική δομή (10) παρέχεται για χορήγηση χημικού(-ών) κάνναβης (14) στη συγκέντρωση αίματος κάποιου. Η δομή περιλαμβάνει ένα στρώμα υποστήριξης (11) το οποίο φέρει το(-α) χημικό(-ά) κάνναβης. Τα χημικά περιέχονται μέσα σε μία μεμβράνη (35) επάνω στο στρώμα υποστήριξης ή μέσα σε μία κοιλότητα (12) διαμορφωμένη μέσα στο στρώμα υποστήριξης. Εναλλακτικά, μπορεί να χρησιμοποιηθεί ένα άνοιγμα (43) σε ένα δευτερεύον στρώμα (42) που επικαλύπτει το στρώμα υποστήριξης για δημιουργία της κοιλότητας. Η δομή εφαρμόζεται στο δέρμα κάποιου έτσι ώστε τα χημικά κάνναβης να έρχονται σε επαφή με το δέρμα. Ένα πολυμερικό υλικό (22) το οποίο είναι αναμεμιγμένο με την κάνναβη και τοποθετημένο μέσα στην κοιλότητα ή μία μεμβράνη επάνω στην κοιλότητα μπορούν να χρησιμοποιηθούν για έλεγχο της ροής του(-ων) χημικού(-ών) κάνναβης στη συγκέντρωση του αίματος. Σε έναν εναλλακτικό σχεδιασμό, ένα πορώδες υλικό (34) εμποτισμένο με το(-α) χημικό(-ά) κάνναβης μπορεί να χρησιμοποιηθεί για συγκράτηση του(-ων) χημικού(-ών) μέσα στην κοιλότητα. Εξαιτίας του σχετικά χαμηλού διαδερμικού ρυθμού ροής των υλικών κάνναβης, είναι προτιμητέα η χρησιμοποίηση ενισχυτικών διαπερατότητας σε συνδυασμό με το φορέα κάνναβης ή τις κοιλότητες αποθήκευσης ή τα κολλητικά στρώματα που έρχονται σε επαφή με το δέρμα (13).
CY20061100291T 2000-09-05 2006-03-02 Δομες και μεθοδοι για χορηγηση κανναβης σε ασθενεις CY1104990T1 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/655,634 US6328992B1 (en) 1997-03-03 2000-09-05 Cannabinoid patch and method for cannabis transdermal delivery

Publications (1)

Publication Number Publication Date
CY1104990T1 true CY1104990T1 (el) 2009-11-04

Family

ID=24629717

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100291T CY1104990T1 (el) 2000-09-05 2006-03-02 Δομες και μεθοδοι για χορηγηση κανναβης σε ασθενεις

Country Status (10)

Country Link
US (1) US6328992B1 (el)
EP (1) EP1186298B1 (el)
AT (1) ATE313320T1 (el)
AU (1) AU785275B2 (el)
CA (1) CA2356020C (el)
CY (1) CY1104990T1 (el)
DE (1) DE60116011T2 (el)
DK (1) DK1186298T3 (el)
ES (1) ES2253331T3 (el)
PT (1) PT1186298E (el)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8449908B2 (en) * 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
US20020111377A1 (en) * 2000-12-22 2002-08-15 Albany College Of Pharmacy Transdermal delivery of cannabinoids
US10004684B2 (en) * 2001-02-14 2018-06-26 Gw Pharma Limited Pharmaceutical formulations
US8034843B2 (en) * 2002-02-01 2011-10-11 Gw Pharma Limited Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions
GB0202385D0 (en) * 2002-02-01 2002-03-20 Gw Pharma Ltd Compositions for the treatment of nausea,vomiting,emesis,motion sicknes or like conditions
WO2003066130A2 (en) * 2002-02-07 2003-08-14 Massachusetts Institute Of Technology Transdermal drug delivery systems
IL148244A0 (en) * 2002-02-19 2002-09-12 Yissum Res Dev Co Anti-nausea and anti-vomiting activity of cannabidiol compounds
EP1539069A4 (en) * 2002-05-31 2007-11-14 Univ Mississippi TRANSMUCOSAL DELIVERY OF CANNABINOIDS
DE10226494A1 (de) * 2002-06-14 2004-01-08 Lts Lohmann Therapie-Systeme Ag Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen
US8906413B2 (en) * 2003-05-12 2014-12-09 Supernus Pharmaceuticals, Inc. Drug formulations having reduced abuse potential
WO2005000830A1 (en) * 2003-06-24 2005-01-06 Gw Pharma Limited Pharmaceutical compositions comprising cabbinochreme type compounds
BRPI0416268A (pt) * 2003-11-05 2007-12-11 Unimed Pharmaceuticals Inc composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla
TWI436991B (zh) * 2004-11-22 2014-05-11 Euro Celtique Sa 用於純化反-（-）-△９-四氫大麻酚與反-（＋）-△９-四氫大麻酚之方法
TWI366460B (en) * 2005-06-16 2012-06-21 Euro Celtique Sa Cannabinoid active pharmaceutical ingredient for improved dosage forms
NZ567029A (en) 2005-09-29 2011-09-30 Amr Technology Inc Process for production of delta-9- tetrahydrocannabinol
US20110150766A1 (en) * 2006-07-07 2011-06-23 Royds Robert B Transdermal patch with fatal overdose protection
US20080008747A1 (en) * 2006-07-07 2008-01-10 Royds Robert B Transdermal patch
US20100184848A1 (en) * 2006-07-14 2010-07-22 William Abraham Wine Transdermal formulations of synthetic cannabinoids and nano colloidal silica
DE102007006244B4 (de) * 2007-02-08 2012-03-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System zur Verabreichung wasserlöslicher Wirkstoffe
JP5224163B2 (ja) * 2007-07-24 2013-07-03 コスメディ製薬株式会社 経皮吸収テープ製剤
WO2009018389A1 (en) * 2007-07-30 2009-02-05 Alltranz Inc. Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same
US20090247619A1 (en) * 2008-03-06 2009-10-01 University Of Kentucky Cannabinoid-Containing Compositions and Methods for Their Use
US20090259176A1 (en) * 2008-04-09 2009-10-15 Los Gatos Research, Inc. Transdermal patch system
WO2010150245A1 (en) * 2009-06-24 2010-12-29 Tikun Olam Ltd. Pharmaceutical and cosmeceutical compositions containing cannabis flower and seed extracts
US20110038915A1 (en) * 2009-08-14 2011-02-17 Eduardo Jose Gonzalez Chewing Gum Formula for Enhancing Psycho-Spirituality
US9155713B2 (en) * 2011-03-03 2015-10-13 Mark Stephen Saia Method and apparatus for alcohol administration and therapeutic treatments using same
US8758826B2 (en) 2011-07-05 2014-06-24 Wet Inc. Cannabinoid receptor binding agents, compositions, and methods
US10319475B1 (en) 2014-06-13 2019-06-11 Enigami Systems, Inc. Method and apparatus for determining relationships between medications and symptoms
CA2956919C (en) 2014-07-21 2022-07-19 Glia, Llc Method for treating radiotherapy- and chemotherapy-associated cognitive or emotional impairment with cannabinoids
US11707556B2 (en) 2015-01-22 2023-07-25 Alps South, LLC Phase change material for thermal therapy and delivery of active ingredients
US10028904B2 (en) 2014-12-04 2018-07-24 Wisconsin Alumni Research Foundation Transdermal cannabinoid formulations
US9375417B2 (en) 2014-12-04 2016-06-28 Mary's Medicinals LLC Transdermal cannabinoid formulations
US20160220593A1 (en) * 2015-02-02 2016-08-04 Axim Biotechnologies, Inc. Cannabinoid and sugar alcohol complex, methods to make and use
US9962340B2 (en) * 2015-06-09 2018-05-08 Life Tech Global, Llc Device and method for the transdermal delivery of cannabidiol
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
US10272125B2 (en) * 2015-09-14 2019-04-30 Life Tech Global, Llc Transdermal delivery of cannabidiol with other active moieties including cannabinoids
LT6486B (lt) * 2016-04-13 2018-01-10 UAB "SatiMed" Aliejinio gelio kompozicija su aktyviausiais junginiais iš c. sativa ir m. arvensis ir jos pateikimo sistema, skirta giliųjų audinių uždegimo ir skausmo mažinimui
WO2018034793A1 (en) 2016-07-21 2018-02-22 Alps South, LLC Phase change material for thermal therapy and delivery of active ingredients
WO2018111616A1 (en) 2016-12-16 2018-06-21 Kimberly-Clark Worldwide, Inc. Application device for a fluid delivery apparatus and method of use
CA3046795A1 (en) * 2016-12-16 2018-06-21 Sorrento Therapeutics, Inc. Attachment band for a fluid delivery apparatus and method of use
ES2898083T3 (es) 2016-12-16 2022-03-03 Sorrento Therapeutics Inc Aparato de suministro de líquidos y procedimiento de montaje
JP7008709B2 (ja) 2016-12-16 2022-01-25 ソレント・セラピューティクス・インコーポレイテッド 制御アセンブリを有する流体送達装置及びその使用方法
CN116271481A (zh) 2016-12-16 2023-06-23 索伦托治疗有限公司 用于给予适合治疗偏头痛或丛集性头痛的药物的方法
KR20230031372A (ko) 2016-12-16 2023-03-07 소렌토 쎄라퓨틱스, 인코포레이티드 가스 추출 디바이스를 갖는 유체 전달 장치 및 그 이용 방법
WO2018125037A1 (en) * 2016-12-27 2018-07-05 John Garland Medical marijuana patch
GB2561262B (en) * 2017-07-13 2019-03-20 Dentmed Ltd A targeted drug delivery pad
EP3654942A1 (en) 2017-07-20 2020-05-27 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Pharmaceutical film compositions for delivery of lipophilic compounds into and/or across the skin
WO2019038739A1 (en) * 2017-08-24 2019-02-28 Zephyrious Health, Inc. APPROPRIATE TRANSDERMIC FORMULATIONS FOR THE ADMINISTRATION OF NATURAL PRODUCTS COMPRISING VEGETABLE FLOUR AND ADHESIVE
WO2019079402A2 (en) * 2017-10-17 2019-04-25 Life Tech Global, Llc IMPROVED ADMINISTRATION SYSTEMS FOR FRACTIONS COMPRISING ENHANCED COMBINATIONS OF CBD, FORMULATIONS AND CHIMERS
EP3823598A2 (en) 2018-07-18 2021-05-26 Glatt Gmbh Immediate release formulations of cannabinoids
US10897925B2 (en) 2018-07-27 2021-01-26 Joseph Pandolfino Articles and formulations for smoking products and vaporizers
US20200035118A1 (en) 2018-07-27 2020-01-30 Joseph Pandolfino Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes
EP3856172A4 (en) * 2018-09-28 2022-10-05 Visceral Therapeutics Inc. PHARMACEUTICALLY ACTIVE CANNABIS-BASED COMPOSITIONS AND METHODS FOR USE IN THE TREATMENT OF GASTROINTESTINAL CONDITIONS
EP3723740A4 (en) * 2018-10-15 2020-10-21 Vardi, Amnon SLOW RELEASE CANNABINOIDS AND PRODUCTS THEREOF
US20220233464A1 (en) * 2019-05-17 2022-07-28 Future Foam, Inc. Cannabidiol infused foam element or surface
US11090346B2 (en) 2019-05-28 2021-08-17 Inbold Inc. Cannabinoid composition and method of sublingual, buccal and oral mucosa delivery
EP4017477A1 (en) * 2019-08-21 2022-06-29 Pure Green Pharmaceuticals, Inc. Medical apparatus with cannabis sativa l.
CA3156257A1 (en) * 2019-10-03 2021-04-08 Starton Therapeutics, Inc. TRANSDERMAL DELIVERY OF DRONABINOL
US12016829B2 (en) * 2019-10-11 2024-06-25 Pike Therapeutics Inc. Pharmaceutical composition and method for treating seizure disorders
US20210177740A1 (en) * 2019-12-11 2021-06-17 Joel Studin Transpore delivery of cannabinoid and uses thereof
WO2021138710A1 (en) * 2020-01-09 2021-07-15 Sg Ventures Pty Limited Substrate for use in a transdermal patch or dressing
US20210236687A1 (en) * 2020-01-31 2021-08-05 Pac-Dent, Inc. Cannabinoid-based oral hemostatic compositions
CA3187582A1 (en) * 2020-08-17 2022-02-24 Fotios M. Plakogiannis Pharmaceutical compositions and methods for treating parkinson's disease
US20220087948A1 (en) * 2020-09-18 2022-03-24 Nanovibronix, Inc. Transdermal patch of a portable ultrasound-generating system for improved delivery of therapeutic agents and associated methods of treatment
EP4255416A1 (en) * 2020-12-03 2023-10-11 Pike Therapeutics Inc. Transdermal pharmaceutical formulations comprising cbd or thc for the treatment of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US302116A (en) * 1884-07-15 Jean baptist alois db winteb
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US6113940A (en) * 1997-03-03 2000-09-05 Brooke; Lawrence L. Cannabinoid patch and method for cannabis transdermal delivery

Also Published As

Publication number Publication date
ATE313320T1 (de) 2006-01-15
AU6554001A (en) 2002-03-07
AU785275B2 (en) 2006-12-14
ES2253331T3 (es) 2006-06-01
DK1186298T3 (da) 2006-05-08
US6328992B1 (en) 2001-12-11
CA2356020A1 (en) 2002-03-05
DE60116011D1 (de) 2006-01-26
PT1186298E (pt) 2006-05-31
DE60116011T2 (de) 2006-08-24
EP1186298A2 (en) 2002-03-13
EP1186298B1 (en) 2005-12-21
CA2356020C (en) 2006-12-19
EP1186298A3 (en) 2003-01-02

Similar Documents

Publication Publication Date Title
CY1104990T1 (el) Δομες και μεθοδοι για χορηγηση κανναβης σε ασθενεις
HUP0303386A2 (hu) Transzdermális terápiás rendszer abszorbeálószereket és csatornaképzőket tartalmazó hatóanyag-áthatlan fedőbevonata vagy lehúzható védőrétege
AR245885A1 (es) Panal desechable con configuracion anatomica.
DE50112720D1 (de) Transdermales therapeutisches system mit hochdispersem siliziumdioxid
ATE526038T1 (de) Implantierbares medizinprodukt mit kontinuierlichem mittel-konzentrationsgefälle
DE60124917D1 (de) Mikrovorrichtung und verfahren zur herstellung
MXPA02005797A (es) Metodos y dispositivos electroquimicos para su uso en la determinacion de concentraciones de analitos con hematocrito corregido.
DE69414502T2 (de) Medizinische Vorrichtung zur Verabreichung von Aktivsubstanzen oder Arzneistoffen in sehr niedriger Dosis, insbesondere von homöopatischen Arzneistoffen
ES2041006T3 (es) La utilizacion de membranas asimetricas en dispositivos de suministro.
ES2077646T3 (es) Prepolimeros utiles en dispositivos biomedicos.
DK1450740T3 (da) Sårforbinding
AU4946801A (en) Method of preventing short sampling of a capillary or wicking fill device
CY1105878T1 (el) Βελτιωμενο συστημα διαδepμικης χορηγησης
EE04656B1 (et) Ventileerimisseade kasutamiseks r?ivaesemetel v?imaldamaks inimkeha hingamist ning meetod sellise ventileerimisseadme valmistamiseks
ES2061030T3 (es) Sistema de tratamiento antitrombogenico de la sangre.
DE60109396D1 (de) Teststreifen zur Bestimmung von Dialysatzusammensetzung
PE20000671A1 (es) Dispositivo desechable para el manejo de orina
DE59001522D1 (de) Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen.
ATE346617T1 (de) Kontrollierte freisetzung von düften durch nicht- gewebte beutel
DE50306743D1 (de) Hydrophiles compositmaterial
DE69530217D1 (de) Eine mikrodialysevorrichtung
CO5060463A1 (es) Articulo absorbente
BR7802407U (pt) Sanitário para cães
CO4940372A1 (es) Hoja de mascara facial para eliminar espinillas
FI20000133A (fi) HB-GAM-tyyppisten beetta-laskos rakenteiden lääketieteellinen ja kemiallinen käyttö proteiinien vuorovaikutuksessa hepariini-sokerirakenteiden kanssa